High sensitivity C-reactive protein (hs-CRP) is a marker of low-grade sustained inflammation. Omega-3 (n-3) fatty acids have anti-inflammatory properties and are associated with reduced cardiovascular disease (CVD) risk. The aim of this study was to investigate whether plasma n-3 fatty acid concentration is related to hs-CRP concentration. A total of 124 free-living adults, were divided into tertiles of plasma hs-CRP (o1.0, 1.0-3.0 and 43.0 mg/l). Body composition and anthropometric measurements were recorded. Hs-CRP was analysed using immunoassays and fatty acids were measured by gas chromatography. Plasma hs-CRP concentration was negatively correlated with total n-3 fatty acids (P ¼ 0.05), eicosapentaenoic acid (EPA; P ¼ 0.002) and docosapentaenoic acid (DPA; P ¼ 0.01). The highest hs-CRP tertile (43.0 mg/l) had significantly lower concentrations of total n-3 fatty acids, EPA and DPA, when compared with the other tertiles (Po0.05). This study provides evidence that in healthy individuals, plasma n-3 fatty acid concentration is inversely related to hs-CRP concentration, a surrogate marker of CVD risk.
Introduction
Inflammation plays an important role in all stages of atherosclerosis. High sensitivity C-reactive protein (Hs-CRP) is an acute-phase inflammatory mediator mainly regulated by interleukin (IL)-6 in the liver and has been shown to predict future cardiovascular disease (CVD) events. To date, several large-scale studies confirm circulating levels of hs-CRP to independently predict future CVD events in individuals without known CVD (as reviewed by Clearfield, 2005) .
The inverse relationship between the consumption of oily fish, fish oil and CVD risk is well established. Conversely, the relationship between omega-3 (n-3) fatty acids and surrogate markers of CVD risk are less clear (Balk et al., 2006) . Observational data suggests that n-3 fatty acids are cardioprotective, have anti-inflammatory properties, reduce hypertension, inhibit thrombosis and arrhythmia and improve arterial compliance (Kris-Etherton et al., 2002) .
In this study, we investigate the relationship between plasma n-3 fatty acids and hs-CRP concentration in healthy individuals.
Subjects and methods
A total of 127 adults were recruited from the general community of Newcastle, Australia. Individuals with diabetes mellitus, hepatic/renal disease, chronic inflammatory conditions (that is, arthritis, gout), cancer, and pregnant or lactating women, those using anti-hypertensive/inflammatory medication, individuals taking fish oil supplements, those on a restricted diet and individuals who smoked tobacco, were excluded from the study. A full medical history was collected from all individuals. Individuals with an hs-CRP concentration X10.0 mg/l (n ¼ 3) were also excluded, given that acute inflammatory conditions are associated with hs-CRP concentrations of 10-50 mg/l. The final study population comprised 124 individuals (46 males and 78 females). All participants gave written informed consent, and the study was approved by the Human Research Ethics Committee of The University of Newcastle, Australia.
All measurements were taken following a 410 h overnight fast. Anthropometric measurements were taken while participants were dressed in light clothing, without shoes.
Venous blood samples were collected and prepared by centrifuging and aliquots were collected and stored at À80 1C until further analysis. Fatty acid compositions of plasma lipids were determined using an acetyl chloride methylation procedure (Lepage and Roy, 1986) . Fatty acid methyl esters were quantified using gas chromatography (Hewlett Packard 6890). Fatty acid results are reported as % of total fatty acids.
Plasma hs-CRP was measured by high sensitivity ELISA method (Hunter New England Area Pathology Service), with a minimal detection level of 0.15 mg/l. Participants were stratified into hs-CRP tertiles, according to CVD risk cut points proposed by the American Heart Association (o1.0 mg/l ¼ low-risk; 1.0-3.0 mg/l ¼ average-risk; 43.0 mg/l ¼ high-risk; Pearson et al., 2003) .
Data are expressed as mean±s.d. Comparisons between groups were calculated by one-way ANOVA with Tukey's HSD post hoc testing. Pearson's correlation coefficient was used to analyse relationships between plasma hs-CRP concentration, anthropometric measures and n-3 fatty acids concentration. Po0.05 was considered significant. All analyses were carried out using SPSS (version 15.0, SPSS Inc., Chicago, IL, USA).
Results
The average participant age was 47.7 ± 11.9 years. Anthropometric and biochemical characteristics are presented in Table 1 . Body weight was significantly greater in the highest hs-CRP tertile (43.0 mg/l) when compared with the middle tertile (1.0-3.0 mg/l; P ¼ 0.01). Body mass index (BMI) was significantly greater in the highest tertile when compared to the lowest (P ¼ 0.003) and middle (P ¼ 0.003) tertiles. Plasma hs-CRP concentrations were significantly different between each of the three groups.
Plasma total n-3 fatty acids, eicosapentaenoic acid (EPA) and docosapentaenoic acid (DPA) were negatively correlated with hs-CRP concentration. As can be seen in Figure 1 , a significant inverse trend among total n-3 fatty acids, EPA and DPA with hs-CRP concentration was evident (P ¼ 0.05, r 2 ¼ 0.189; Po0.01, r 2 ¼ 0.263; and P ¼ 0.01, r 2 ¼ 0.216, respectively).
Discussion
Our results demonstrate an inverse correlation between plasma n-3 fatty acids and hs-CRP concentration in healthy individuals. The importance of this study is such that individuals with higher plasma hs-CRP (43.0 mg/l) concentration according to risk cut points, have significantly n-3 fatty acids and hs-CRPlower plasma n-3 fatty acids. Given that n-3 fatty acids are cardioprotective, this inverse correlation with hs-CRP, a surrogate marker of CVD risk, could represent a possible mechanism by which n-3 fatty acids are involved in CVD risk reduction.
Observational studies have demonstrated a relationship between dietary n-3 fatty acid intake with hs-CRP (Balk et al., 2006) . In a cross-sectional analysis of 859 adults by Pischon et al. (2003) , a modest inverse relationship between dietary n-3 fatty acid intake and hs-CRP levels was found. Together, with our findings, these observations support a relationship between n-3 fatty acid and hs-CRP, which may provide a mechanism by which CVD risk is reduced in populations with higher n-3 fatty acids intake. Furthermore, n-3 fatty acids may be more important in primary, rather than secondary, CVD risk reduction.
Conversely, intervention studies investigating the effect of n-3 fatty acid supplementation on hs-CRP concentration have shown conflicting results. In healthy controls, supplementation with 1.5 g/day n-3 fatty acids for 12 weeks did not lower hs-CRP concentration, relative to a placebo group (Geelen et al., 2004) . In a similar study with lower baseline hs-CRP concentrations, no effect of n-3 fatty acid supplementation was reported (Madsen et al., 2003) . Increasing fish oil intake has shown to reduce in vitro synthesis of some inflammatory mediators (IL-6, IL-1b, IL-1a and tumournecrosis factor-a); however, in several placebo controlled trials, fish oil does not reduce cytokine expression or functional activity of neutrophils, monocytes or lymphocytes in healthy individuals (Endres et al., 1989; Kew et al., 2004) .
Our study shows an inverse association between plasma levels of n-3 fatty acids and hs-CRP; however, we must acknowledge that this finding may be due, in part, to residual confounding factors such as habitual diet, body weight, lipoprotein concentration, BMI and lifestyle influences. Questions regarding the optimal dose and type of n-3 fatty acids for risk reduction still exist, hence further studies are needed to evaluate their efficacy.
We report that plasma n-3 fatty acid concentration is inversely correlated with hs-CRP in healthy individuals, when stratified into tertiles representing CVD risk cut points. Findings from this study support previous observations that n-3 fatty acids may improve cardiovascular health in healthy individuals.
